Induction of melanoma in TPras transgenic mice

Marianne Broome Powell, Paul R. Gause, Paul Hyman, Jacalyn Gregus, Maria Lluria-Prevatt, Ray Nagle, G. Tim Bowden

Research output: Contribution to journalArticle

74 Scopus citations

Abstract

In order to study the oncogenesis of melanocytes, transgenic mouse lines were established that express a mutated human Ha-ras (TPras) gene in pigment producing cells. The ras transgenic mice exhibit an altered phenotype, including melanocytic hyperplasia and a muted agouti coat, indicative of hyperproliferative melanocytes. These mice and their wild-type littermates have been subjected to a variety of carcinogenesis protocols, including 7,12-dimethylbenz[α]anthracene (DMBA), 12-O-tetradecanoylphorbol-13-acetate (TPA) and UV radiation exposure. Topical DMBA treatment of TPras mice resulted in a high incidence of melanomas. Metastatic lesions were observed in skin, lungs and lymph nodes. TPA treatment of TPras mice induced a small number of papillomas but no nevi or melanomas. UV light exposures induced papillomas in negative littermate and melanomas in some albino TPras mice. These results show that melanocytes expressing an activated Ha-ras in the TPras transgenic mice are susceptible to induction of melanoma by DMBA.

Original languageEnglish (US)
Pages (from-to)1747-1753
Number of pages7
JournalCarcinogenesis
Volume20
Issue number9
DOIs
StatePublished - Sep 8 1999

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Induction of melanoma in TPras transgenic mice'. Together they form a unique fingerprint.

  • Cite this

    Powell, M. B., Gause, P. R., Hyman, P., Gregus, J., Lluria-Prevatt, M., Nagle, R., & Bowden, G. T. (1999). Induction of melanoma in TPras transgenic mice. Carcinogenesis, 20(9), 1747-1753. https://doi.org/10.1093/carcin/20.9.1747